SPENG Block Versus Suprascapular and Axillary Nerve Blocks for Pain After Shoulder Arthroscopy

Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-70
SponsorIzmir City Hospital

About this trial

This prospective, randomized, patient- and assessor-blinded, single-center non-inferiority trial will compare the analgesic efficacy of the Shoulder Posterior Pericapsular Nerve Group (SPENG) block with combined posterior suprascapular and axillary nerve blocks in adults undergoing elective shoulder arthroscopy under general anesthesia. Both groups will receive the same total volume and concentration of local anesthetic. The primary outcome will be the highest resting Numeric Rating Scale pain score recorded during the first 24 postoperative hours. Secondary outcomes will include block performance time, sensory block success in suprascapular and axillary nerve territories, opioid consumption, time to rescue analgesia, motor function, diaphragmatic function, postoperative recovery quality, patient satisfaction, and block-related complications.

Eligibility criteria

Qualifiers

Age 18 to 70 years

American Society of Anesthesiologists (ASA) physical status I-III

Scheduled to undergo elective shoulder arthroscopy under general anesthesia

Able to understand the Numeric Rating Scale for pain assessment

Disqualifiers

Known allergy or hypersensitivity to local anesthetics used in the study

Infection at the planned block injection site

Coagulopathy or ongoing anticoagulant therapy that cannot be appropriately interrupted for peripheral nerve block

Pre-existing neurological deficit affecting the operative upper extremity

Trial design

Treatments tested in this trial

  • Shoulder Posterior Pericapsular Nerve Group (SPENG) Block
  • Combined Posterior Suprascapular and Axillary Nerve Blocks

Treatment groups

60 Participants
are divided into 2 treatment groups

Locations

This trial has no locations

Sponsors and collaborators